Metraipolis › archive › dc_7b83a7d5a802
Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults — Europe PMC PMID:41218073
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41218073
- DOI
- 10.1371/journal.pone.0335182
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T08:50:38.501Z
- SHA-256 of the archived text
3b941c81dee5f1610f5363145d5b92d40faa2ace1fc0a05bcd02a536914dd0e1- Stable URL of this page
https://metraipolis.com/documento/dc_7b83a7d5a802
How to cite
Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults — Europe PMC PMID:41218073 — Europe PMC (en), https://europepmc.org/article/MED/41218073 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7b83a7d5a802 (Metraipolis archive dc_7b83a7d5a802, sha256 3b941c81dee5f1610f5363145d5b92d40faa2ace1fc0a05bcd02a536914dd0e1)
BibTeX
@misc{dc7b83a7d5a802,
title = {Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults — Europe PMC PMID:41218073},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41218073},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7b83a7d5a802; sha256 3b941c81dee5f1610f5363145d5b92d40faa2ace1fc0a05bcd02a536914dd0e1},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41218073. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Little is known about public perceptions of antivirals for the treatment of mild-to-moderate COVID-19 in the United States (US). Our objective was to explore adult perceptions toward COVID-19 antivirals to improve outreach communications about antivirals for COVID-19. Methods: During July 2022, potential respondents ≥18 years were randomly sampled from a national opt-in internet panel, with oversampling of African Americans, Hispanics, and adults ≥65 years. Respondents were asked about sociodemographic factors, and knowledge, attitudes, and perceptions regarding COVID-19 antivirals. Results were weighted to represent the non-institutionalized US adult population. Results: Among 1,155 respondents, 51% were female, 21% were 50-64 years, and 19% were ≥65 years. Compared to younger age groups, a greater proportion of adults ≥65 years were knowledgeable about COVID-19 antivirals and would take them if they tested positive or their doctor recommended them. Adults ≥65 years and those reporting immunosuppression or disability had the highest rates of willingness to take antivirals. For all groups, the proportion of people willing to take antivirals increased by >20% if recommended by their doctor. Respondents in the 50-64 and ≥65 groups who were sure they would take COVID-19 antivirals were more likely to be fully vaccinated and less likely to be living in isolation. Conclusion: Groups that are less likely to have been vaccinated, those living in isolation, and those not sure about whether they would take an antiviral or not may be at risk for not receiving treatment to prevent severe COVID-19 outcomes. However, trust in doctor recommendations may be enough to overcome individual patient concerns about COVID-19 antivirals. Targeted initiatives to educate those at risk for severe COVID-19 outcomes about the effectiveness of antivirals may be needed to further lower this population's risk of severe COVID-19. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2025 (prima pubblicazione 2025-11-11). Identificativi: PMID 41218073 · PMCID PMC12604800 · DOI 10.1371/journal.pone.0335182. Descrittori MeSH principali: Antiviral Agents; Health Knowledge, Attitudes, Practice; COVID-19; COVID-19 Drug Treatment. Pagina: https://europepmc.org/article/MED/41218073 — https://doi.org/10.1371/journal.pone.0335182. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T08:20:26.652Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.